Literature DB >> 129433

Plasma inhibitors of lymphocyte response to phytohaemagglutinin in children with recurrent infections.

M G Fitzgerald, C S Hosking.   

Abstract

A survey of the immunological status of 175 children with recurrent infections showed that the plasmas of fifteen patients contained an inhibitor of lymphocyte response to phytohaemagglutinin (PHA). The inhibitors could be subdivided into two groups. One type of inhibitor acted only on the patients' lymphocytes (autologous-only). The other type also inhibited the response of control lymphocytes to PHA and in the mixed lymphocyte reaction (homologous). Plasma inhibitors of both types inhibit the response of rabbit lymphocytes to PHA. Patients with a plasma inhibitor frequently have a raised resting lymphocyte DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 129433      PMCID: PMC1444958     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  In vitro methods in cell-mediated immunity: a progress report.

Authors: 
Journal:  Cell Immunol       Date:  1973-03       Impact factor: 4.868

2.  Serum inhibitors of lymphocyte responses.

Authors:  R A Gatti
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

3.  Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.

Authors:  N Suciu-Foca; J Buda; J McManus; T Thiem; K Reemtsma
Journal:  Cancer Res       Date:  1973-10       Impact factor: 12.701

Review 4.  Chalones. Specific endogenous mitotic inhibitors.

Authors:  J C Houck; H Hennings
Journal:  FEBS Lett       Date:  1973-05-15       Impact factor: 4.124

5.  Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor.

Authors:  M Knowles; D Hughes; E A Caspary; E J Field
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

6.  Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis.

Authors:  G M Levene; J L Turk; D J Wright; A G Grimble
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

7.  Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor.

Authors:  D E McFarlin; J J Oppenheim
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

8.  Leukemic serum inhibition of phytohemagglutinin-induced transformation.

Authors:  G B Humphrey; J Lankford; S Oleinick; R Nitschke
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

9.  Characterization of a serum inhibitor of MLC reactions.

Authors:  R A Gatti; E J Yunis; R A Good
Journal:  Clin Exp Immunol       Date:  1973-03       Impact factor: 4.330

10.  Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.

Authors:  W M Newberry; J P Sanford
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

View more
  7 in total

1.  Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. The significance of serum inhibition and rosette inhibitory factors.

Authors:  B Maisch; P Schuff-Werner; P A Berg; K Kochsiek
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

Review 2.  Autoantibodies and serum inhibition factors (sif) in patients with myocarditis.

Authors:  B Maisch; P A Berg; K Kochsiek
Journal:  Klin Wochenschr       Date:  1980-03-03

3.  Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions.

Authors:  G Bjune; R S Barnetson
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

4.  Modification by suppressor cells and serum factors of the cell-mediated immune response in experimental pyelonephritis.

Authors:  T Miller; L Scott; E Stewart; D North
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

5.  The detection of circulating immune complexes in children with recurrent infections and their treatment with human immunoglobulins.

Authors:  M Delire; P L Masson
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

6.  Effect of gammaglobulin injection on circulating immune complexes in various diseases.

Authors:  H U Schwenk; H W Baenkler
Journal:  Eur J Pediatr       Date:  1979-04-25       Impact factor: 3.183

7.  Immunological studies in angioimmunoblastic lymphadenopathy.

Authors:  A Skibin; T Yeremiyahu; A Keynan; M R Quastel
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.